Trial Profile
Effects of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Total Knee Replacement (TKA).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Dec 2012
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 18 Dec 2012 Primary endpoints amended as reported by ClinicalTrials.gov.
- 16 Apr 2012 Actual end date Jul 2011 added as reported by ClinicalTrials.gov.
- 16 Apr 2012 Company added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.